MarkWide Research

Sale!

Stem Cell Therapy Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: October, 2022
No of Pages: 159
Delivery Format: PDF+Excel

$2,950.00

Stem Cell Therapy Market size surpassed USD 8.9 billion in 2020 and is expected to witness growth rate of over 10.6% from 2021 to 2027. Constant government support and initiatives for research and development activities of regenerative medicine in developed areas is likely to drive the industry demand. For instance, according to the government of Australia, the Medical Research Future Fund’s (MRFF) announced Stem Cell Therapies Mission as a part of the 2019-20 budget. The government funded nearly USD 150 million for research and development of safe and effective treatments accessible to all diseased population.
The global spread of COVID-19 infection did not have material effect on the industry. Various research institutes and government organizations across the regions were focusing on rapid and effective technologies for the treatment of life-threatening diseases including COVID-19 outbreak. Moreover, several clinical trials were begun with respective to regenerative medicine. However, it is in the initial stage of study in relation to the various different single umbilical cord stem cell market studied.

Rising prevalence of rare genetic diseases

Increasing prevalence of rare genetic diseases is anticipated to augment the stem cell therapy market growth. Every year, millions of people suffer from rare diseases such as thalasemmia, phenylketonuria, cystic fibrosis and others. For instance, according to the Firstpost report, in 2020, there were 40 million carriers of thalasemmia in India, which represent one in eight of thalassemia carriers in India. Therefore, conventional therapies and medications have proven less effective in curing these diseases and thus, individuals have now started preferring advanced stem cell therapies that should elevate the industry statistics. Furthermore, advances in stem cell therapies that improve recovery speed in patients suffering from malignancies is expected to boost demand.

Ethical issues associated with stem cell therapy may slow the market

Several safety and ethical issues are associated with the use of stem cells, as these stem cells are derived from the human embryo, thereby limiting the development of human embryonic stem cell (hESC). Additionally, deriving pluripotent stem cell lines from embryos and oocytes is an intense topic of disputes. Medical risks associated with the oocyte retrieval and several other risks related to experimental interventions may impact the demand for stem cell therapies negatively.

Autologous stem cell process is tedious and time consuming

Autologous stem cell therapy segment is projected to grow at around 10.5% through 2027. The autologous stem cell therapy provides high compatibility with humans immune system, as the patients are their own donors of stem cell. Similarly, the risk of graft rejection is less and the possibilities of using these cells without undergoing clinical trial is poised to spur the market revenue. However, these stem cells require tremendous degree of manipulation and may even need gene modification. Hence, the overall process is tedious and time consuming that may lower the pace of segmental growth.

High success rate of stem cell therapies in treatment of various form of cancer

Oncology segment accounted for about 37.1% of the stem cell therapy market share in 2020 and is predicted to observe similar trends through 2027. Increasing prevalence of cancer cases coupled with high success rate of stem cell therapies in treatment of cancer is propelling the market expansion. For instance, as per the Memorial Sloan Kettering Cancer Center, the predicted rate of one-year survival for patients undergoing an allogeneic bone marrow transplantation was more than 60%.

Hospitals are collaborating with research institute to upgrade its treatment offering

Hospitals end-use segment is estimated to register nearly 10.6% gains till 2027. Growing preference for stem cell therapies provided in hospitals to avoid complications caused owing to the invasive methods including surgical procedures is spurring the industry size. Currently, hospitals are affiliated with research laboratories and academic institutes that conducts extensive research for the development of innovative stem cell therapies. Collaborations with research institutes allow hospitals to upgrade its treatment offerings, thereby, positively influence the market statistics.

High favorable government activities in North America

North America stem cell therapy market valued at USD 3.7 billion in 2020 and is forecast to expand at 10.3% CAGR from 2021 to 2027. Considerable regional growth can be attributed to the favourable government initiatives. For instance, in November 2020, government of Canada and JDRF Canada announced a new research funding of USD 6 million to accelerate stem cell-based therapies for type 1 diabetes. In addition, technological advancements in regenerative medicine will further support the market demand.

Growth strategies of market players are focused on increasing the customer base

Few of the notable stem cell therapy market players are Astellas Pharma Inc, Novadip Biosciences, MEDIPOST, Fujifilm Cellular Dynamics, DiscGenics, Mesoblast Ltd and Takeda Pharmaceutical among others. Companies adopt strategies such as novel product launch, mergers and acquisitions to foster business.

Recent industry developments:

  • In March 2021, Novadip Biosciences received approval from U.S. FDA for the Company’s Investigational New Drug (IND) application for its autologous cell therapy product NVD-003. The product is used for the treatment of Congenital Pseudarthrosis of the Tibia (CPT). This strategy is likely to enhance their product offerings and expand their customer base, thereby strengthening its market position.
  • In January 2020, Astellas Pharma Inc. entered into the licensing agreement with Allele Biotechnology and Pharmaceuticals, Inc., a company engaged in the development of cell-based therapeutics. This agreement aimed at expanding Astellas access to Allele’s induced pluripotent stem cell (iPSC) technologies for various cell therapy. This strategy enabled company to offer innovative solution as well as maintain its long-term business relation.

This stem cell therapy market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments

Market, By Type

  • Allogenic stem cell therapy
  • Autologous stem cell therapy

Market, By Therapeutic Area

  • Oncology
  • Orthopedic
  • Cardiovascular
  • Neurology
  • Others

Market, By End-use

  • Hospitals
  • Clinics
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Chapter 1   Methodology

1.1    Market definition

1.2    Base estimates & working

1.2.1    North America

1.2.2    Europe

1.2.3    Asia pacific

1.2.4    Latin America

1.2.5    Middle East & Africa

1.3    Forecast parameters

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1    Paid sources

1.5.1.2    Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    Stem cell therapy industry 3600 synopsis, 2016 – 2027

2.1.1    Business trends

2.1.2    Type trends

2.1.3    Therapeutic area trends

2.1.4    End-use trends

2.1.5    Regional trends

Chapter 3   Stem Cell Therapy Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2016 – 2027

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Advancements in regenerative medicine in North America & Europe

3.3.1.2    Increasing government initiatives for stem cell therapy in developed as well as developing countries

3.3.1.3    Rising awareness regarding availability of stem cell therapy in developing countries

3.3.1.4    Growing prevalence of chronic diseases

3.3.2    Industry pitfalls & challenges

3.3.2.1    High cost of stem cell therapy

3.3.2.2    Ethical issues associated with stem cell therapy

3.4    Growth potential analysis

3.4.1    By type

3.4.2    By therapeutic area

3.4.3    By end-use

3.5    COVID-19 impact analysis

3.6    Stem cell therapy ecosystem analysis

3.7    Porter’s analysis

3.8    Competitive landscape, 2020

3.8.1    Company matrix analysis

3.9    PESTEL analysis

Chapter 4   Stem Cell Therapy Market, By Type

4.1    Key segment trends

4.2    Allogenic stem cell therapy

4.2.1    Market size, by region, 2016-2027 (USD Million)

4.3    Autologous stem cell therapy

4.3.1    Market size, by region, 2016-2027 (USD Million)

Chapter 5   Stem Cell Therapy Market, By Therapeutic Area

5.1    Key segment trends

5.2    Oncology

5.2.1    Market size, by region, 2016-2027 (USD Million)

5.3    Orthopedic

5.3.1    Market size, by region, 2016-2027 (USD Million)

5.4    Cardiovascular

5.4.1    Market size, by region, 2016-2027 (USD Million)

5.5    Neurology

5.5.1    Market size, by region, 2016-2027 (USD Million)

5.6    Others

5.6.1    Market size, by region, 2016-2027 (USD Million)

Chapter 6   Stem Cell Therapy Market, By End-use

6.1    Key segment trends

6.2    Hospitals

6.2.1    Market size, by region, 2016-2027 (USD Million)

6.3    Clinics

6.3.1    Market size, by region, 2016-2027 (USD Million)

6.4    Others

6.4.1    Market size, by region, 2016-2027 (USD Million)

Chapter 7   Stem Cell Therapy Market, By Region

7.1    Key regional trends

7.2    North America

7.2.1    Market size, by country, 2016-2027 (USD Million)

7.2.2    Market size, by type, 2016-2027 (USD Million)

7.2.3    Market size, by therapeutic area, 2016-2027 (USD Million)

7.2.4    Market size, by end-use, 2016-2027 (USD Million)

7.2.5    U.S.

7.2.5.1    Market size, by type, 2016-2027 (USD Million)

7.2.5.2    Market size, by therapeutic area, 2016-2027 (USD Million)

7.2.5.3    Market size, by end-use, 2016-2027 (USD Million)

7.2.6    Canada

7.2.6.1    Market size, by type, 2016-2027 (USD Million)

7.2.6.2    Market size, by therapeutic area, 2016-2027 (USD Million)

7.2.6.3    Market size, by end-use, 2016-2027 (USD Million)

7.3    Europe

7.3.1    Market size, by country, 2016-2027 (USD Million)

7.3.2    Market size, by type, 2016-2027 (USD Million)

7.3.3    Market size, by therapeutic area, 2016-2027 (USD Million)

7.3.4    Market size, by end-use, 2016-2027 (USD Million)

7.3.5    Germany

7.3.5.1    Market size, by type, 2016-2027 (USD Million)

7.3.5.2    Market size, by therapeutic area, 2016-2027 (USD Million)

7.3.5.3    Market size, by end-use, 2016-2027 (USD Million)

7.3.6    UK

7.3.6.1    Market size, by type, 2016-2027 (USD Million)

7.3.6.2    Market size, by therapeutic area, 2016-2027 (USD Million)

7.3.6.3    Market size, by end-use, 2016-2027 (USD Million)

7.3.7    France

7.3.7.1    Market size, by type, 2016-2027 (USD Million)

7.3.7.2    Market size, by therapeutic area, 2016-2027 (USD Million)

7.3.7.3    Market size, by end-use, 2016-2027 (USD Million)

7.3.8    Italy

7.3.8.1    Market size, by type, 2016-2027 (USD Million)

7.3.8.2    Market size, by therapeutic area, 2016-2027 (USD Million)

7.3.8.3    Market size, by end-use, 2016-2027 (USD Million)

7.3.9    Spain

7.3.9.1    Market size, by type, 2016-2027 (USD Million)

7.3.9.2    Market size, by therapeutic area, 2016-2027 (USD Million)

7.3.9.3    Market size, by end-use, 2016-2027 (USD Million)

7.3.10    Russia

7.3.10.1    Market size, by type, 2016-2027 (USD Million)

7.3.10.2    Market size, by therapeutic area, 2016-2027 (USD Million)

7.3.10.3    Market size, by end-use, 2016-2027 (USD Million)

7.4    Asia Pacific

7.4.1    Market size, by country, 2016-2027 (USD Million)

7.4.2    Market size, by type, 2016-2027 (USD Million)

7.4.3    Market size, by therapeutic area, 2016-2027 (USD Million)

7.4.4    Market size, by end-use, 2016-2027 (USD Million)

7.4.5    Japan

7.4.5.1    Market size, by type, 2016-2027 (USD Million)

7.4.5.2    Market size, by therapeutic area, 2016-2027 (USD Million)

7.4.5.3    Market size, by end-use, 2016-2027 (USD Million)

7.4.6    China

7.4.6.1    Market size, by type, 2016-2027 (USD Million)

7.4.6.2    Market size, by therapeutic area, 2016-2027 (USD Million)

7.4.6.3    Market size, by end-use, 2016-2027 (USD Million)

7.4.7    India

7.4.7.1    Market size, by type, 2016-2027 (USD Million)

7.4.7.2    Market size, by therapeutic area, 2016-2027 (USD Million)

7.4.7.3    Market size, by end-use, 2016-2027 (USD Million)

7.4.8    South Korea

7.4.8.1    Market size, by type, 2016-2027 (USD Million)

7.4.8.2    Market size, by therapeutic area, 2016-2027 (USD Million)

7.4.8.3    Market size, by end-use, 2016-2027 (USD Million)

7.4.9    Australia

7.4.9.1    Market size, by type, 2016-2027 (USD Million)

7.4.9.2    Market size, by therapeutic area, 2016-2027 (USD Million)

7.4.9.3    Market size, by end-use, 2016-2027 (USD Million)

7.5    Latin America

7.5.1    Market size, by country, 2016-2027 (USD Million)

7.5.2    Market size, by type, 2016-2027 (USD Million)

7.5.3    Market size, by therapeutic area, 2016-2027 (USD Million)

7.5.4    Market size, by end-use, 2016-2027 (USD Million)

7.5.5    Brazil

7.5.5.1    Market size, by type, 2016-2027 (USD Million)

7.5.5.2    Market size, by therapeutic area, 2016-2027 (USD Million)

7.5.5.3    Market size, by end-use, 2016-2027 (USD Million)

7.5.6    Mexico

7.5.6.1    Market size, by type, 2016-2027 (USD Million)

7.5.6.2    Market size, by therapeutic area, 2016-2027 (USD Million)

7.5.6.3    Market size, by end-use, 2016-2027 (USD Million)

7.5.7    Argentina

7.5.7.1    Market size, by type, 2016-2027 (USD Million)

7.5.7.2    Market size, by therapeutic area, 2016-2027 (USD Million)

7.5.7.3    Market size, by end-use, 2016-2027 (USD Million)

7.6    MEA

7.6.1    Market size, by country, 2016-2027 (USD Million)

7.6.2    Market size, by type, 2016-2027 (USD Million)

7.6.3    Market size, by therapeutic area, 2016-2027 (USD Million)

7.6.4    Market size, by end-use, 2016-2027 (USD Million)

7.6.5    South Africa

7.6.5.1    Market size, by type, 2016-2027 (USD Million)

7.6.5.2    Market size, by therapeutic area, 2016-2027 (USD Million)

7.6.5.3    Market size, by end-use, 2016-2027 (USD Million)

7.6.6    Saudi Arabia

7.6.6.1    Market size, by type, 2016-2027 (USD Million)

7.6.6.2    Market size, by therapeutic area, 2016-2027 (USD Million)

7.6.6.3    Market size, by end-use, 2016-2027 (USD Million)

7.6.7    UAE

7.6.7.1    Market size, by type, 2016-2027 (USD Million)

7.6.7.2    Market size, by therapeutic area, 2016-2027 (USD Million)

7.6.7.3    Market size, by end-use, 2016-2027 (USD Million)

Chapter 8   Company Profiles

8.1    Competitive dashboard

8.2    Astellas Pharma Inc

8.2.1    Business overview

8.2.2    Financial data

8.2.3    Product landscape

8.2.4    Strategic outlook

8.2.5    SWOT analysis

8.3    Capricor Therapeutics

8.3.1    Business overview

8.3.2    Financial data

8.3.3    Product landscape

8.3.4    Strategic outlook

8.3.5    SWOT analysis

8.4    Cellectis

8.4.1    Business overview

8.4.2    Financial data

8.4.3    Product landscape

8.4.4    Strategic outlook

8.4.5    SWOT analysis

8.5    Fujifilm Cellular Dynamics

8.5.1    Business overview

8.5.2    Financial data

8.5.3    Product landscape

8.5.4    Strategic outlook

8.5.5    SWOT analysis

8.6    ThermoGenesis Holdings, Inc

8.6.1    Business overview

8.6.2    Financial data

8.6.3    Product landscape

8.6.4    Strategic outlook

8.6.5    SWOT analysis

8.7    DiscGenics

8.7.1    Business overview

8.7.2    Financial data

8.7.3    Product landscape

8.7.4    Strategic outlook

8.7.5    SWOT analysis

8.8    Mesoblast Ltd

8.8.1    Business overview

8.8.2    Financial data

8.8.3    Product landscape

8.8.4    Strategic outlook

8.8.5    SWOT analysis

8.9    Novadip Biosciences

8.9.1    Business overview

8.9.2    Financial data

8.9.3    Product landscape

8.9.4    Strategic outlook

8.9.5    SWOT analysis

8.10    MEDIPOST

8.10.1    Business overview

8.10.2    Financial data

8.10.3    Product landscape

8.10.4    Strategic outlook

8.10.5    SWOT analysis

8.11    Takeda Pharmaceuticals

8.11.1    Business overview

8.11.2    Financial data

8.11.3    Product landscape

8.11.4    Strategic outlook

8.11.5    SWOT analysis

Data Tables

TABLE 1.    Stem cell therapy market size, 2016 – 2027 (USD Million)

TABLE 2.    Stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 3.    Stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 4.    Stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 5.    Industry impact forces

TABLE 6.    Allogenic stem cell therapy market size, by region, 2016 – 2027 (USD Million)

TABLE 7.    Autologous stem cell therapy market size, by region, 2016 – 2027 (USD Million)

TABLE 8.    Oncology market size, by region, 2016 – 2027 (USD Million)

TABLE 9.    Orthopedic market size, by region, 2016 – 2027 (USD Million)

TABLE 10.    Cardiovascular market size, by region, 2016 – 2027 (USD Million)

TABLE 11.    Neurology size, by region, 2016 – 2027 (USD Million)

TABLE 12.    Hospitals market size, by region, 2016 – 2027 (USD Million)

TABLE 13.    Clinics size, by region, 2016 – 2027 (USD Million)

TABLE 14.    Others market size, by region, 2016 – 2027 (USD Million)

TABLE 15.    North America Stem cell therapy market size, by country, 2016 – 2027 (USD Million)

TABLE 16.    North America stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 17.    North America stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 18.    North America stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 19.    U.S. stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 20.    U.S. stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 21.    U.S. stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 22.    Canada stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 23.    Canada stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 24.    Canada stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 25.    Europe stem cell therapy market size, by country, 2016 – 2027 (USD Million)

TABLE 26.    Europe stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 27.    Europe stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 28.    Europe stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 29.    Germany stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 30.    Germany stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 31.    Germany stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 32.    UK stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 33.    UK stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 34.    UK stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 35.    France stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 36.    France stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 37.    France stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 38.    Italy stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 39.    Italy stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 40.    Italy stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 41.    Spain stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 42.    Spain stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 43.    Spain stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 44.    Russia stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 45.    Russia stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 46.    Russia stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 47.    Asia Pacific stem cell therapy market size, by country, 2016 – 2027 (USD Million)

TABLE 48.    Asia Pacific stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 49.    Asia Pacific stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 50.    Asia Pacific stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 51.    Japan stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 52.    Japan stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 53.    Japan stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 54.    China stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 55.    China stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 56.    China stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 57.    India stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 58.    India stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 59.    India stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 60.    South Korea stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 61.    South Korea stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 62.    South Korea stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 63.    Australia stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 64.    Australia stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 65.    Australia stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 66.    Latin America stem cell therapy market size, by country, 2016 – 2027 (USD Million)

TABLE 67.    Latin America stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 68.    Latin America stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 69.    Latin America stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 70.    Brazil stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 71.    Brazil stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 72.    Brazil stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 73.    Mexico stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 74.    Mexico stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 75.    Mexico stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 76.    Argentina stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 77.    Argentina stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 78.    Argentina stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 79.    MEA stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 80.    MEA stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 81.    MEA stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 82.    Saudi Arabia stem cells therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 83.    Saudi Arabia stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 84.    Saudi Arabia stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 85.    South Africa stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 86.    South Africa stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 87.    South Africa stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)

TABLE 88.    UAE stem cell therapy market size, by type, 2016 – 2027 (USD Million)

TABLE 89.    UAE stem cell therapy market size, by therapeutic area, 2016 – 2027 (USD Million)

TABLE 90.    UAE stem cell therapy market size, by end-use, 2016 – 2027 (USD Million)
Charts & Figures

FIG 1.     Stem cell therapy industry 360º synopsis, 2016 – 2027

FIG 2.     Industry segmentation

FIG 3.     Stem cell therapy market size, 2016 – 2027 (USD Million)

FIG 4.     Growth potential analysis, by type

FIG 5.     Growth potential analysis, by therapeutic area

FIG 6.     Growth potential analysis, by end-use

FIG 7.     Porter’s analysis

FIG 8.     Company matrix analysis, 2020

FIG 9.     PESTEL analysis

FIG 10.  Key segmental trends, by type

FIG 11.  Key segmental trends, by therapeutic area

FIG 12.  Key segmental trends, by end-use

FIG 13.  Key regional trends

FIG 14. Competitive dashboard, 2020

Market, By Type

  • Allogenic stem cell therapy
  • Autologous stem cell therapy

Market, By Therapeutic Area

  • Oncology
  • Orthopedic
  • Cardiovascular
  • Neurology
  • Others

Market, By End-use

  • Hospitals
  • Clinics
  • Others

Astellas Pharma Inc, Novadip Biosciences, MEDIPOST, Fujifilm Cellular Dynamics, DiscGenics, Mesoblast Ltd and Takeda Pharmaceutical among others.

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF